MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on October 20, 2006; DOI: 10.1124/mol.106.028241


0026-895X/07/7101-303-313$20.00
Mol Pharmacol 71:303-313, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.028241v1
71/1/303    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shi, J.
Right arrow Articles by Muma, N. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shi, J.
Right arrow Articles by Muma, N. A.

Phosphorylation of G{alpha}11 Protein Contributes to Agonist-Induced Desensitization of 5-HT2A Receptor Signaling

Ju Shi, Bozena Zemaitaitis, and Nancy A. Muma

Department of Pharmacology and Experimental Therapeutics, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois

Agonist treatment causes desensitization of many G proteincoupled receptor systems. Recent advances have delineated changes in receptors in the desensitization response; however, the role of G proteins remains unclear. We investigated the role of phosphorylation of G{alpha}q/11 proteins in agonist-induced desensitization of serotonin 2A (5-HT2A) receptors. In an embryonic rat cortical cell line (A1A1v), 24-h treatment with 100 nM (-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI), a 5-HT2A/2C receptor agonist, decreased DOI-stimulated inositol phosphate accumulation and increased the phosphorylation of G{alpha}q/11 proteins, as demonstrated by immunoprecipitation of G{alpha}q/11 and both incorporation of 32P phosphate and labeling with a S/T/Y phosphorylation-dependent antibody. Treatment with DOI for 30 min induced desensitization but did not increase phosphorylation of G{alpha}q/11 proteins, suggesting that different mechanisms are involved in desensitization after short- and long-term treatments. Mutation of S154A in a protein kinase C (PKC) and calcium/calmodulin dependent kinase (CaMK) consensus site in G{alpha}11 significantly reduced DOI-stimulated phosphorylation of G{alpha}11 and DOI-induced desensitization of 5-HT2A receptor signaling. Inhibition of PKC and CaMK attenuated phosphorylation of G{alpha}q/11 proteins and DOI-induced desensitization of 5-HT2A receptors. Expression of G{alpha}11 S154D, a phosphorylation mimic, reduced DOI-stimulated inositol phosphate accumulation. DOI treatment for 24 h also produced heterologous desensitization, as indicated by decreased bradykinin-stimulated inositol phosphate accumulation. These data suggest that phosphorylation of G{alpha}11 protein by PKC and CaMK contributes to agonistinduced homologous desensitization of 5-HT2A receptor signaling as well as heterologous desensitization. The phosphorylation of G{alpha} protein represents a novel mechanism involved in regulation of receptor signaling and agonist-induced desensitization of G protein-coupled receptors.


Received June 22, 2006; accepted October 20, 2006

Address correspondence to: Dr. Nancy A. Muma, Department of Pharmacology Loyola University Chicago, Stritch School of Medicine, 2160 South First Avenue, Maywood, IL 60153. E-mail: nmuma{at}lumc.edu




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
J. Shi, K. J. Damjanoska, R. K. Singh, G. A. Carrasco, F. Garcia, A. J. Grippo, M. Landry, N. R. Sullivan, G. Battaglia, and N. A. Muma
Agonist Induced-Phosphorylation of G{alpha}11 Protein Reduces Coupling to 5-HT2A Receptors
J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 248 - 256.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Chakrabarti and A. R. Gintzler
Phosphorylation of G{alpha}s Influences Its Association with the {micro}-Opioid Receptor and Is Modulated by Long-Term Morphine Exposure
Mol. Pharmacol., September 1, 2007; 72(3): 753 - 760.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. K. Singh, J. Shi, B. W. Zemaitaitis, and N. A. Muma
Olanzapine Increases RGS7 Protein Expression via Stimulation of the Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling Cascade
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 133 - 140.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics